Open Access

Prevention of cardiovascular diseases in the post-COVID19 era

Event: ESC Congress 2022
Topic: Prevention
Session type: Satellite Symposium
Sponsored by Abbott
Date: 28 August 2022
Time: 17:45 - 18:30

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

4 presentations in this session

Welcome and introduction.

Speaker: Professor W. Koenig (Munich, DE)

The burden of CV disease and the value of cardiac biomarkers in the post-COVID19 era.

Speaker: Professor N. Sattar (Glasgow, GB)

Setting troponin as a key risk stratification tool in CVD prevention: practical recommendations.

Speaker: Associate Professor D. Farmakis (Athens, GR)

ACR and lipid point-of-care testing as tools for CVD prediction and management.

Speaker: Professor O. Schnell (Munich, DE)

4 speakers from this session

Professor Wolfgang Koenig

German Heart Center of Munich, Munich (Germany)
23 presentations
0 follower

Professor Naveed Sattar

BHF Glasgow Cardiovascular Research Centre, Glasgow (United Kingdom of Great Britain & Northern Ireland)
33 presentations

Associate Professor Dimitrios T Farmakis

National & Kapodistrian University of Athens Medical School, Athens (Greece)
17 presentations
1 follower

Professor Oliver Schnell

Sciarc GmbH, Munich (Germany)
3 presentations
0 follower

This platform is supported by

logo Novo Nordisk